![Maja Suter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maja Suter
Keine laufenden Positionen mehr
Profil
Ms. Maja Suter is a Director at CELLnTec Advanced Cell Systems AG.
She is on the Board of Directors at CELLnTec Advanced Cell Systems AG.
Ehemalige bekannte Positionen von Maja Suter
Unternehmen | Position | Ende |
---|---|---|
CELLnTec Advanced Cell Systems AG
![]() CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CELLnTec Advanced Cell Systems AG
![]() CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Health Technology |